Business Context and Reporting Period
Company: OPKO Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 9, 2011
Event: Entry into a Material Definitive Agreement for a public offering of common stock.
Key Financial Metrics
This filing reports on a capital raise transaction rather than operational financial performance. Key transaction metrics include:
- Shares Offered (Firm): 27,000,000 shares of common stock.
- Offering Price: $3.75 per share.
- Overallotment Option: Underwriters granted an option to purchase up to 4,050,000 additional shares within 30 days.
- Expected Net Proceeds: Approximately $96.4 million (excluding overallotment) or approximately $110.7 million (if overallotment is exercised in full).
- Underwriters: Jefferies & Company, Inc. and J.P. Morgan Securities LLC.
Note: The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes
The primary material change is the execution of an underwriting agreement to sell equity securities. This transaction is expected to significantly increase the company's cash position upon closing, scheduled for or about March 14, 2011.
Guidance, Outlook, and Risks
- Lock-Up Period: Each director and executive officer has agreed not to sell, transfer, or dispose of company securities for 90 days following the date of the final prospectus supplement, subject to customary exceptions.
- Closing Conditions: The offering is subject to customary closing conditions.
- Regulation FD: The company issued a press release on March 9, 2011, announcing the pricing of the offering.
Investor Verification Checklist
- Verify the final closing date of the offering (expected March 14, 2011).
- Confirm whether the underwriters exercise the 4,050,000 share overallotment option.
- Review the full text of the Underwriting Agreement (Exhibit 1.1) for specific indemnification and covenant details.
- Check subsequent filings for the actual net proceeds received after deducting all offering expenses.